EXAS (Exact Sciences Inc.) Margin dodolan operasi

Exact Sciences - logo grafis emiten EXAS

Exact Sciences relies on the expanding early cancer diagnostics sector and the growing number of insured patients. However, dependence on a single product and pressure from Medicare regulators create financial risks. Prospects are tied to the rollout of Cologuard Plus and the transition to profitability. The operating margin level visualizes business efficiency, and the value of -4.80 shows the current magnitude of this metric.

exactsciences.com (EXAS): Rentabilitas kegiatan operasi saka 04.07.2022 nganti 04.04.2026

EXAS (Exact Sciences): rincian analitis lan laporan miturut indikator

Analisis fundamental perusahaan:EXAS, Exact Sciences
Produk dadi Exact Sciences Inc.

Steady demand for non-invasive cancer diagnostics and insurance coverage generate a predictable revenue stream for Exact Sciences (EXAS), despite significant marketing expenditures. The current operating margin reflects the share of profit from core operations before interest and taxes, allowing investors to assess cost management efficiency and the company's actual capital cushion amid market volatility.

Perusahaan pesaing

Margin dodolan operasi A|DGX: Tingkat bathi operasi|Margin operasi ILMN|Rasio bathi operasi RVTY|Bio-Rad - Margin dodolan operasi|Anbio - Rentabilitas operasi|soterahealth.com - Margin operasi|Tingkat bathi operasi QDEL (QuidelOrtho)|OPK (OPKO Corp) - Margin dodolan operasi|Rentabilitas dodolan miturut bathi operasi CDNA|MRVI (Maravai LifeSciences Holdings) - Margin operasi|Rentabilitas dodolan operasi Fulgent Genetics Inc FLGT|Rentabilitas operasi fluidigm.com (LAB)|Margin dodolan operasi Cytek Bio CTKB|Margin operasi OSUR (OraSure Technologies)|Tingkat bathi adhedhasar bathi operasi Exagen Inc.|MDXH - Rentabilitas operasi|Rentabilitas kegiatan operasi Lucid Diagnostics Inc LUCD|PRE: Margin operasi|Insight Molecular (IMDX) - Margin operasi|TRIB (trinitybiotech.com) - Margin operasi|prophaselabs.com (PRPH) - Rentabilitas kegiatan operasi|Margin operasi AIMD|Rentabilitas kegiatan operasi Co-Diagnostics Inc|Margin operasi HSCS (Heart Test Laboratories, Inc.)|Tingkat bathi operasi BMRA|CDIO - Rentabilitas operasi|Rentabilitas dodolan operasi onconetix.gcs-web.com|Virax Biolabs Group (VRAX) - Rentabilitas operasi|BJDX - Rentabilitas kegiatan operasi|AWH (Aspira Women's Health, Inc.) - Margin operasi|Accelerate Diagnostics, Inc (AXDX) - Rentabilitas kegiatan operasi|Margin operasi CNTG|ENZ - Rentabilitas dodolan operasi|Tingkat bathi operasi Fresh2 Group Ltd|Genetic Technologies (GENE) - Rentabilitas dodolan operasi|ME - Rentabilitas operasi|Rentabilitas kegiatan operasi Psychemedics Corp PMD